Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

100.96
-0.4000-0.39%
Post-market: 99.99-0.9677-0.96%19:59 EST
Volume:5.31M
Turnover:537.43M
Market Cap:149.67B
PE:53.99
High:101.69
Open:100.92
Low:100.90
Close:101.36
52wk High:109.50
52wk Low:85.98
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.41
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.87
EPS(LYR):1.26
ROE:12.49%
ROA:5.76%
PB:6.40
PE(LYR):80.17

Loading ...

Elutia Q3 revenue falls short of estimates, gross margin improves

Reuters
·
Nov 07

Boston Scientific Director Ellen M. Zane Reports Sale of Common Shares

Reuters
·
Nov 07

Elutia Inc. reports Q3 net sales of $3.3 million

Reuters
·
Nov 07

EVP & Group President Cardiology Joseph Michael Fitzgerald Reports Disposal of Boston Scientific Corporation Common Shares

Reuters
·
Nov 05

This GE, Amazon-backed electric-plane maker sees strong demand for its IPO

Dow Jones
·
Nov 04

Should Boston Scientific's Strong 2025 Results and Leadership Change Prompt Action From BSX Investors?

Simply Wall St.
·
Nov 04

Boston Scientific’s Financial Outlook: Key Risks and Challenges Highlighted in Latest Annual Report

TIPRANKS
·
Nov 04

Boston Scientific Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 04

Boston Scientific Executives to Join Wolfe Research Healthcare Conference

Reuters
·
Nov 03

Boston Scientific Announces Upcoming Investor Conference Schedule

THOMSON REUTERS
·
Nov 03

Boston Scientific posts Q3 net income of $755 million

Reuters
·
Nov 03

Diversify Out of AI With Boston Scientific Stock -- Barron's

Dow Jones
·
Nov 01

Stock investors head into November saying thanks to a market that keeps on giving

Dow Jones
·
Oct 31

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

Dow Jones
·
Oct 30

Boston Scientific Director Ellen M. Zane Reports Sale of Common Shares

Reuters
·
Oct 29

Daiwa Securities Adjusts Price Target on Boston Scientific to $124 From $121, Maintains Buy Rating

MT Newswires Live
·
Oct 28

Boston Scientific’s SALT Study: A Closer Look at Device Safety and Performance

TIPRANKS
·
Oct 28

Boston Scientific’s Vercise DBS Registry: A Key Update for Investors

TIPRANKS
·
Oct 28

Boston Scientific’s Latest Study: A New Era in Chronic Pain Management?

TIPRANKS
·
Oct 28

Boston Scientific’s POLARx Study: A Key Update for Investors

TIPRANKS
·
Oct 28